Athena Safa Sefat: Then and Now
Athena Safa Sefat is a Senior Research Scientist and a former Wigner Fellow in the Materials Science & Technology Division of the Physical Sciences Directorate at Oak Ridge National Laboratory.
Read more
Feature Expert
Colleen Iversen on Belowground Ecology
After working on a climate change experiment that showed plants adapt to additional carbon dioxide by putting extra carbon into their roots, Colleen Iverson has been on a mission to understand the role of roots in the environment, especially the tundra.
Read more
Africana Studies Professors Discuss State of Race Relations in U.S.
Five Buffalo State College faculty members weighed in on the current race relations climate following ongoing protests.
Read moreAtlantic Hurricane Season and Mortgage Default Risk
Maryland Smith finance professor and former risk executive Clifford Rossi’s new study examines the future implications of a predicted increase in hurricane activity for the likes of borrowers and mortgage credit investors.
Read more
Team Sports Risks Go Well Beyond Injury During the Pandemic
Annabelle de St. Maurice, MD, MPH, co-chief infection prevention officer for UCLA Health, speaks on The Centers for Disease Control and Prevention’s guide for youth sports to resume.
Read moreAmericans face greater risks if U.S. pulls from World Health Organization, say WVU health and policy experts
The Trump administration’s plan to withdraw the United States from the World Health Organization, effective July 6, 2021, could reshape global diplomacy and weaken public health efforts at home, particularly amid the COVID-19 pandemic, according to West Virginia University experts in health and public policy.
Read more
COVID-19: What you should know if you have sickle cell disease
If you have sickle cell disease, you are at higher risk than the general population for severe complications from COVID-19.
Read moreJuly is National UV Safety Month
July is UV Safety Month, the perfect time to raise awareness about the risk of developing sun-related skin cancer. Rutgers Cancer Institute expert shares tips about how to reduce skin cancer risk during the summer months when UV rays are the strongest.
Read moreHow to Celebrate the Fourth of July During the Pandemic
While parks and friends’ backyards will be open to celebrate July 4, it’s still important to interact safely with others amid the ongoing COVID-19 pandemic. Even though more places are reopening in Chicago and around the state, there still is a risk of infection with the COVID-19 virus when outside your home.
Read more
Expert in Early Phase Therapeutics Joins NYU Langone Health as Associate Director for Clinical Research at Perlmutter Cancer Center
Janice M. Mehnert, MD, a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, has been appointed associate director for clinical research at NYU Langone Health’s Perlmutter Cancer Center. She assumes her post July 1, 2020.
Read moreMIPT geneticist Pavel Volchkov shares his thoughts on using genetic mechanisms to oppose diseases, and talks about his vision of science communication.
Progress can be safely considered synonymous with science. We have seen a tangible improvement over the last hundred years. But who are the people behind such a mysterious sphere as science? What is its future focus? And why are academic partnerships so important now?
Explains MIPT geneticist Pavel Volchkov
What Parents Should Know about Multisystem Inflammatory Syndrome in Children (MIS-C)
MIS-C stands for multisystem inflammatory syndrome in children. Formerly called pediatric inflammatory multisystem syndrome, or PIMS, it describes a new health condition seen in children who have been infected with novel coronavirus, recovered from it and later have an immune response that results in symptoms of significant levels of inflammation in organ systems. MIS-C is similar in some ways to other inflammatory conditions like Kawasaki disease and toxic shock syndrome. Children who have MIS-C generally did not have obvious symptoms when they were infected with novel coronavirus, like cough, and generally were healthy prior to developing MIS-C.
Read more